Skip to main content
Log in

Integrated pharmaceutical care in the community: (how) can we turn vision into reality?

  • Pharmaceutical Care: Current Viewpoint
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

This article provides a summary of main messages of the annual Steve Hudson memorial lecture presented by Tobias Dreischulte at the 42nd European Society of Clinical Pharmacy symposium in Prague in 2013. An exploration of what is meant by integrated pharmaceutical care, the design and pilot testing of a model for continuous quality improvement of medication use designed to facilitate care integration, and opportunities and challenges of implementing the model in practice are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. European Society of Cardiology. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12(10):1360–420.

    Article  Google Scholar 

  2. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as a cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329:15–9.

    Article  PubMed  Google Scholar 

  3. Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2006;63(2):136–47.

    Article  PubMed  Google Scholar 

  4. Leendertse AJ, Egberts AC, Stoker LJ, et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168(17):1890–6.

    PubMed  Google Scholar 

  5. Howard R, Avery A, Bissell P. Causes of preventable drug-related hospital admissions: a qualitative study. Qual Saf Health Care. 2007;17:109–16.

    Article  Google Scholar 

  6. Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21 century. Washington, DC: National Academy Press; 2001.

    Google Scholar 

  7. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract. 1999;8(1):2–4.

    Google Scholar 

  8. Holland R, Desborough J, Goodyer L, et al. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol. 2008;65(3):303–16.

    Article  PubMed  Google Scholar 

  9. Bryant LJM, Coster G, Gamble GD, et al. The General Practitioner-Pharmacist Collaboration (GPPC) study: a randomised controlled trial of clinical medication reviews in community pharmacy. Int J Pharm Pract. 2011;19(2):94–105.

    Article  PubMed  Google Scholar 

  10. Community Pharmacy Medicines Management Project Evaluation Team. The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. Fam Pract. 2007;24(2):189–200.

    Article  Google Scholar 

  11. Dreischulte T, Grant A, McCowan C, et al. Quality and safety of medication use in primary care: consensus validation of a new set of explicit medication assessment criteria and prioritisation of topics for improvement. BMC Clin Pharmacol. 2012;12(1):5.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–24.

    Article  PubMed  Google Scholar 

  13. Higashi T, Shekelle PG, Solomon DH, et al. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med. 2004;140(9):714–20.

    Article  PubMed  Google Scholar 

  14. Gallagher P, Ryan C, Byrne S, et al. Screening tool of older persons’ potentially inappropriate prescriptions (STOPP) and screening tool to alert doctors to right treatment (START): validation and application to hospitalised elderly patients. Age Ageing. 2008;37:56.

    Article  Google Scholar 

  15. Dreischulte T, Johnson J, McAnaw J, et al. Medication assessment tool to detect care issues from routine data: a pilot study in primary care. Int J Clin Pharm. doi:10.1007/s11096-013-9828-2 [Epub 20 Aug 2013].

  16. Machado M, Bajcar J, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007;41(11):1770–81.

    Article  PubMed  Google Scholar 

  17. Machado M, Bajcar J, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007;41(10):1569–82.

    Article  PubMed  Google Scholar 

  18. Machado M, Nassor N, Bajcar JM, et al. Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management. Ann Pharmacother. 2008;42(9):1195–207.

    Article  PubMed  Google Scholar 

  19. Dreischulte T, Grant A, Donnan P, et al. A cluster randomised stepped wedge trial to evaluate the effectiveness of a multifaceted information technology-based intervention in reducing high-risk prescribing of non-steroidal anti-inflammatory drugs and antiplatelets in primary medical care: the DQIP study protocol. Implement Sci. 2012;7(1):24.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Avery A, Rodgers S, Cantrill J, et al. Protocol for the PINCER trial: a cluster randomised trial comparing the effectiveness of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices. Trials. 2009;10(1):28.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Avery AJ, Rodgers S, Cantrill JA, et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet. 2012;379(9823):1310–9.

    Article  PubMed  Google Scholar 

Download references

Disclosure

During the preparation of this article, the author was supported by the Scottish government health directorates chief scientist office applied research programme grant 07/02.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tobias Dreischulte.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dreischulte, T. Integrated pharmaceutical care in the community: (how) can we turn vision into reality?. Drugs Ther Perspect 30, 65–71 (2014). https://doi.org/10.1007/s40267-013-0095-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40267-013-0095-z

Keywords

Navigation